Revolutionizing treatment for orphan diseases through medication repurposing can improve patient outcomes.
The Coastal Program for Rare Inflammatory Diseases at Vancouver Coastal Health, led by Dr. Luke Chen, aims to accelerate treatments for rare diseases through collaborative research and cost-effective drug repurposing.
In partnership with Every Cure, the program utilizes artificial intelligence and computational pharmacophenomics to identify existing medications for rare diseases, reducing time and cost compared to traditional development.
Uncover the potential of repurposing medications to revolutionize the treatment landscape for orphan diseases and improve patient outcomes.
Author's summary: Revolutionizing rare disease treatment through medication repurposing.